Invesco Pharmaceuticals ETF
ETF- Fund size (USD)
- $600.28M
- Expense Ratio
- 0.58%
- Yield (12 mo)
- 0.91%
- Holdings
- 28
Your view on PJP
Invesco Pharmaceuticals ETF
ETFInvesco- Fund size (USD)
- $600.28M
- Expense Ratio
- 0.58%
- Yield (12 mo)
- 0.91%
- Holdings
- 28
Overview
What the fund invests in, who runs it, and what it costs.
Invesco Pharmaceuticals ETF (PJP) is an Equity fund from Invesco, listed since 2005, with $600.3M in assets under management, a 0.58% expense ratio and a NAV of $129.65 USD.
Overview for Invesco Pharmaceuticals ETF
- Fund Type
- ETF
- Fund Issuer
- Invesco
- Asset Class
- Equity
- Sector
- Financial Services
- Industry
- Asset Management
- Inception Date
- June 23, 2005
- Domicile
- US
- Fund Type
- ETF
- Fund Issuer
- Invesco
- Asset Class
- Equity
- Sector
- Financial Services
- Industry
- Asset Management
- Inception Date
- June 23, 2005
- Domicile
- US
- Fund Type
- ETF
- Fund Issuer
- Invesco
- Asset Class
- Equity
- Sector
- Financial Services
- Industry
- Asset Management
- Inception Date
- June 23, 2005
- Domicile
- US
About this fund
The Invesco Pharmaceuticals ETF (Fund) is based on the Dynamic Pharmaceutical Intellidex Index (Index). The Fund will normally invest at least 90% of its total assets in common stocks that comprise the Index. The Index is designed to provide capital appreciation by thoroughly eva…
Price Chart
Market price history and trading volume.
Key Facts
Cost, yield, size, and the fund's reference data.
Expense Ratio
0.58%
Yield (12 mo)
0.91%
Fund size
$600.28M
Fund Details
Expense Ratio
0.58%
Dividend Yield (TTM)
0.91%
Assets Under Management
$600.28M
NAV
$129.65 USD
Holdings
28
Average Volume
41.9K
Inception Date
June 23, 2005
Asset Class
Equity
Fund Issuer
Invesco
Domicile
US
ISIN
US46137V6627
CUSIP
46137V662
NAV Currency
USD
Expense Ratio
0.58%
Dividend Yield (TTM)
0.91%
Assets Under Management
$600.28M
NAV
$129.65 USD
Holdings
28
Average Volume
41.9K
Inception Date
June 23, 2005
Asset Class
Equity
Fund Issuer
Invesco
Domicile
US
ISIN
US46137V6627
CUSIP
46137V662
NAV Currency
USD
Distributions · last 12 months
Quarterly · 4 payments
| Ex-date | Paid | Amount |
|---|---|---|
| Sep 21, 2026 | Sep 25, 2026 | $0.3014 |
| Jun 22, 2026 | Jun 26, 2026 | $0.2733 |
| Mar 23, 2026 | Mar 27, 2026 | $0.309 |
| Dec 22, 2025 | Dec 26, 2025 | $0.2463 |
| Total, 12 months | $1.13 a share | |
Dividend yield (TTM) 0.91% = $1.13 paid per share in the 12 months to Nov 20, 2026 ÷ the $124.76 price. Past distributions; future payments can differ.
Sectors
How the fund's assets are split across sectors.
- 1Healthcare100.0%
Top sector
Healthcare
Top weight
100.0%
Top 3 weight
100.0%
Holdings
The securities the fund owns, by weight.
Concentration
Top 10 Weight
51.40%
Top 10 Weight
51.40%
Comparables
Funds similar to this one.
Comparable funds
- ASLVAllspring Special Large Value ETFLarge Cap Equity0.35%$209M46
- AVMVAvantis U.S. Mid Cap Value ETFEquity0.20%$831M289
- BRTRiShares Total Return Active ETFFixed Income0.41%$860M2,816
- DXUVDimensional - US Vector Equity ETFUS Equity0.26%$6.3B1,990
- FLRGFIDELITY U.S. MULTIFACTOR ETFEquity0.15%$292M105
- FXGFirst Trust Consumer Staples AlphaDEX FundSector Equity0.63%$218M40
- HAWXiShares Currency Hedged MSCI ACWI ex US ETFEquity0.70%$353M1
More Invesco ETFs
- XSMOInvesco S&P SmallCap Momentum ETFEquity0.35%$2.7B112
- XSVMInvesco S&P SmallCap Value with Momentum ETFEquity0.36%$592M118
- RSPUInvesco S&P 500 Equal Weight Utilities ETFEquity0.40%$543M32
- RWJInvesco S&P SmallCap 600 Revenue ETFEquity0.39%$2.0B596
- RWKInvesco S&P MidCap 400 Revenue ETFEquity0.39%$1.3B398
- RWLInvesco S&P 500 Revenue ETFEquity0.39%$10.3B502
- RZGInvesco S&P SmallCap 600 Pure Growth ETFEquity0.35%$118M126
- RZVInvesco S&P SmallCap 600 Pure Value ETFEquity0.35%$285M157
- SATOInvesco Alerian Galaxy Crypto Economy ETFEquity0.66%$6M60
- SOXQInvesco PHLX Semiconductor ETFEquity0.19%$2.7B31
- SPGPInvesco S&P 500 GARP ETFEquity0.34%$2.1B75
- SPHBInvesco S&P 500 High Beta ETFEquity0.25%$782M100
Fund Holders
Institutions that own shares of this fund.
News
Latest headlines and market coverage.
About this section
Latest headlines and company announcements for this company. Press releases and market coverage, newest first.
